1 employees
Liphorus Pharmaceuticals develops therapeutic antibodies that can be used to treat hypercholesterolemia.
2014
$6.4M
from 2 investors over 2 rounds
Liphorus Pharmaceuticals Inc. raised $6.4M on November 6, 2014
Investors: Sanderling Ventures and Gestion Univalor